Authors:
COONEY GF
SELLERS P
BROWNE B
MANCANO M
SALLAS WM
HEIFETS M
Citation: Gf. Cooney et al., IMPROVED CORRELATION BETWEEN TROUGH CYCLOSPORINE LEVELS AND AUCS FOR NEW ORAL MICROEMULSION FORMULATION, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 104-104
Authors:
SALLAS WM
NEDELMAN JR
SHEINER LB
MELIGENI JA
ROBINSON WT
Citation: Wm. Sallas et al., A NONLINEAR MIXED-EFFECTS PHARMACOKINETIC MODEL COMPARING 2 FORMULATIONS OF CYCLOSPORINE IN STABLE RENAL-TRANSPLANT PATIENTS, Journal of pharmacokinetics and biopharmaceutics, 23(5), 1995, pp. 495-514
Citation: Wm. Sallas, DEVELOPMENT OF LIMITED SAMPLING STRATEGIES FOR CHARACTERISTICS OF A PHARMACOKINETIC PROFILE, Journal of pharmacokinetics and biopharmaceutics, 23(5), 1995, pp. 515-529
Citation: Wm. Sallas et al., PK PD ANALYSIS FOR CYCLOSPORINE, MARKETED AND MICROEMULSION FORMULATIONS, IN PSORIASIS PATIENTS/, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 155-155
Citation: Wm. Sallas et Hf. Schran, LINEAR MIXED EFFECTS MODELS FOR TROUGH CONCENTRATIONS OF CYCLOSPORINE-A AND CYCLOSPORINE-G, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 162-162